We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
+9.93%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$20.6B
AUM Growth
+$1.37B
Cap. Flow
-$108M
Cap. Flow %
-0.52%
Top 10 Hldgs %
24.22%
Holding
1,585
New
42
Increased
433
Reduced
362
Closed
69

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$140M
2
JNJ icon
Johnson & Johnson
JNJ
+$83.9M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$76.7M
4
JPM icon
JPMorgan Chase
JPM
+$56.2M
5
AVGO icon
Broadcom
AVGO
+$55.8M

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$103M
2
BMY icon
Bristol-Myers Squibb
BMY
+$77.8M
3
CTXS
Citrix Systems Inc
CTXS
+$75.4M
4
MET icon
MetLife
MET
+$74.6M
5
ZTS icon
Zoetis
ZTS
+$56.4M

Sector Composition

Rank Sector Weight
1 Technology 27.13%
2 Healthcare 21.68%
3 Financials 14.1%
4 Consumer Discretionary 8.35%
5 Consumer Staples 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADBE icon
26
Adobe
ADBE
$105B
$154M 0.75%
457,249
+165,379
+57% +$52.9M
MCD icon
27
McDonald's
MCD
$193B
$147M 0.71%
557,577
+54,085
+11% +$14.3M
CRM icon
28
Salesforce
CRM
$155B
$144M 0.7%
1,089,072
+199,485
+22% +$29.1M
SPGI icon
29
S&P Global
SPGI
$125B
$140M 0.68%
417,354
-33,892
-8% -$11.2M
BSX icon
30
Boston Scientific
BSX
$68.8B
$134M 0.65%
2,891,500
-1,076,834
-27% -$46.6M
EL icon
31
Estee Lauder
EL
$30.9B
$134M 0.65%
538,568
-164,905
-23% -$36.8M
BMY icon
32
Bristol-Myers Squibb
BMY
$130B
$129M 0.63%
1,793,848
-1,032,048
-37% -$77.8M
INTU icon
33
Intuit
INTU
$91.9B
$123M 0.6%
315,269
-20,647
-6% -$8.19M
ORCL icon
34
Oracle
ORCL
$347B
$122M 0.59%
1,491,176
-316,503
-18% -$24.1M
GOOGL icon
35
Alphabet (Google) Class A
GOOGL
$4.17T
$118M 0.57%
1,341,166
-31,903
-2% -$3.03M
IBM icon
36
IBM
IBM
$217B
$117M 0.57%
831,024
+150,612
+22% +$20.8M
ACN icon
37
Accenture
ACN
$107B
$112M 0.54%
417,977
+37,377
+10% +$10.3M
BRK.B icon
38
Berkshire Hathaway Class B
BRK.B
$1.1T
$110M 0.54%
357,671
+54,908
+18% +$16.3M
NKE icon
39
Nike
NKE
$64.2B
$106M 0.52%
909,905
-1,021,581
-53% -$103M
XOM icon
40
ExxonMobil
XOM
$649B
$105M 0.51%
948,820
+181,855
+24% +$19.5M
ELV icon
41
Elevance Health
ELV
$82.1B
$103M 0.5%
200,969
-51,834
-21% -$26.3M
SYK icon
42
Stryker
SYK
$135B
$103M 0.5%
420,199
+44,658
+12% +$10.1M
AVGO icon
43
Broadcom
AVGO
$1.82T
$101M 0.49%
1,810,150
+1,112,160
+159% +$55.8M
BKNG icon
44
Booking.com
BKNG
$158B
$101M 0.49%
1,251,800
-221,400
-15% -$16.8M
CVS icon
45
CVS Health
CVS
$136B
$101M 0.49%
1,079,846
+16,110
+2% +$1.55M
CSCO icon
46
Cisco
CSCO
$454B
$98M 0.48%
2,056,777
-638,181
-24% -$29M
MS icon
47
Morgan Stanley
MS
$324B
$96.1M 0.47%
1,129,832
-659,689
-37% -$56.2M
SBUX icon
48
Starbucks
SBUX
$119B
$94.9M 0.46%
956,298
-259,258
-21% -$24.5M
A icon
49
Agilent Technologies
A
$39.6B
$94.4M 0.46%
630,859
+77,723
+14% +$11.1M
ISRG icon
50
Intuitive Surgical
ISRG
$127B
$89.9M 0.44%
338,930
+103,680
+44% +$25.3M

Similar funds

KBC Group's Q4 2022 Portfolio in Review

As of Q4 2022, KBC Group held 1,585 positions worth $20.6B, up 7.1% from $19.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

KBC Group's Q4 2022 filing shows 42 new, 433 increased, 362 reduced and 69 closed positions. Its largest new stake was Ferguson: 50,222 shares worth $6.38M. The largest sale was Nike, an estimated $103M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • KBC Group's largest Q4 2022 buy was Ferguson: 50,222 shares worth $6.38M.
  • KBC Group added most to Apple in Q4 2022, an estimated $140M increase.
  • KBC Group's biggest Q4 2022 reduction was Nike, cutting an estimated $103M.
  • KBC Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $75.4M.
  • KBC Group's ten largest holdings make up 24% of its $20.6B portfolio in Q4 2022.
  • KBC Group opened 42 new positions and closed 69 in Q4 2022.
  • KBC Group's portfolio value rose 7.1% quarter-over-quarter to $20.6B.

Based on KBC Group's 13F filing for Q4 2022, filed 13 Feb 2023.